GINKGO BIOWORKS, INC.

Ginkgo Bioworks, Inc. specializes in advanced biotechnological research and genomic surveillance systems, leveraging synthetic biology and high-throughput sequencing to deliver real-time pathogen monitoring and laboratory diagnostics. The company designs and operates scalable genomic testing platforms for public health and defense applications, with deep expertise in traveler-based surveillance, data sharing infrastructure, and rapid-response laboratory networks. Their technical capabilities span microbial genomics, bioinformatics pipeline development, and biosafety-compliant laboratory operations, enabling agile detection and characterization of emerging infectious threats in dynamic environments. A key differentiator is their integration of automated, field-deployable sequencing systems with secure, interoperable data platforms that support federal decision-making during public health emergencies. Ginkgo Bioworks maintains a strong, recurring relationship with the Department of Health and Human Services, delivering critical genomic testing and surveillance services under multiple award IDIQs focused on test surge capacity and nationwide data integration. They also support the Department of Defense on advanced life science R&D initiatives, including environmental biocontrol systems and field-adaptive biotechnologies for extreme conditions, demonstrating their ability to meet mission-critical defense requirements through innovative biological solutions. The contractor’s primary focus lies in medical and testing laboratories (NAICS 621511 and 541380), where they operate as a high-complexity diagnostic and genomic analysis provider, and in life sciences R&D (NAICS 541714 and 541715), where they pioneer applied biotechnology for national security and public health. Their market positioning centers on bridging cutting-edge synthetic biology with operational federal systems, serving as a specialized biotech integrator for mission-driven agencies. Ginkgo Bioworks, Inc. is a privately held entity headquartered in Boston, Massachusetts, with no federal certifications on record. Their geographic presence is anchored in the Boston biotech corridor, positioning them at the nexus of academic research and federal contracting ecosystems.